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Abstract
This study demonstrates rapid and pH-sensitive release of a highly water-soluble fluorescent aqueous content marker,
pyranine, from egg phosphatidylcholine liposomes following incorporation of N-isopropylacrylamide (NIPA) copolymers in
liposomal membranes. The pH-sensitivity of this system correlates with the precipitation of the copolymers at acidic pH. In
vitro release can be significantly improved by increasing the percentage of anchor in the copolymer and thus favoring its
binding to the liposomal bilayer. In the case of liposomes containing a poly(ethylene glycol)^phospholipid conjugate, the
insertion of the pH-sensitive copolymer in the liposomal membrane appears to be sterically inhibited. Dye release from these
formulations at acidic pH can still be achieved by varying the anchor molar ratio and/or molecular mass of the polymers or
by including the latter during the liposome preparation procedure. Removal of unbound polymer results in decreased leakage
only when the copolymer is inserted by incubation with preformed liposomes, but can be overcome by preparing liposomes in
the presence of polymer. Aqueous content and lipid mixing assays suggest contents release can occur without membrane
fusion. The results of this study indicate that the addition of pH-sensitive copolymers of NIPA represents promising strategy
for improving liposomal drug delivery. ß 2000 Elsevier Science B.V. All rights reserved.
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dioctadecylammonium bromide; DMPC, dimyristoyl phosphatidylcholine; DOPE, dioleoyl phosphatidylethanolamine; DPX, p-xylene-
bis-pyrimidium bromide; DSPC, distearoyl phosphatidylcholine; EPC, egg phosphatidylcholine; Hepes, N-(-2-hydroxyethyl)-piperazine-
NP-(2-ethanesulfonic acid); HPTS, 8-hydroxypyrene-1,3,6-trisulfonic acid (pyranine); LCST, lower critical solution temperature; MAA,
methylacrylic acid; MES, 2-N-(morpholino)ethanesulfonic acid; NBD-PE, N-(7-nitro-2,1,3-benzoxadiazol-4-yl) phosphatidylethanol-
amine; NIPA, N-isopropylacrylamide; OA, oleic acid; ODA, octadecyl acrylate; PEAA, poly(2-ethyl-acrylic acid); PEG-DSPE, N-(9-
methoxypoly(oxyethylene)-K-oxycarbonyl)-1,2-distearoyl-sn-3-phosphatidylethanolamine; Rh-PE, N-(lissamine rhodamine B sulfonyl)-
phosphatidylethanolamine; SSL, sterically stabilized liposomes; Suc-DOPE, N-succinyl-dioleoyl phosphatidylethanolamine
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1. Introduction
Liposomes are being increasingly employed to spe-
ci¢cally deliver chemotherapeutic agents, antisense
oligonucleotides, and genes to various therapeutic
targets [1^3]. While signi¢cant progress has been
made in overcoming many of the original obstacles
to e¡ective delivery of these agents via liposomes, the
ability to carefully regulate their bioavailability has,
for the most part, eluded the ¢eld. One approach for
controlling bioavailability has been to design pH-sen-
sitive liposomes, which are stable at neutral pH, but
become destabilized and release their contents upon
acidi¢cation of the endosomal and lysosomal lumens
[4^6]. Thus, drugs are delivered speci¢cally and with
greater e⁄ciency to intracellular sites where they can
elicit their pharmacological responses after endocyto-
sis.
The most studied pH-sensitive liposomes are com-
posed of mildly acidic amphiphiles and unsaturated
phosphatidylethanolamines [7^9]. While e¡ective in
delivering small molecules, such as £uorophores
and antisense oligonucleotides to the cytosol of cells
in culture, they are severely hampered in their
present form under in vivo conditions. Plasma or
serum has been shown to both destabilize some for-
mulations, by causing premature contents leakage,
and reduce the pH-sensitivity of other formulations
[10^13]. In addition, the presence of unsaturated lipid
components, together with an overall negative sur-
face charge results in physical characteristics typi-
cally associated with rapid removal of the liposomes
from the circulation by macrophages of the mono-
nuclear phagocytic system (MPS) [14,15]. The pres-
ence of poly(ethylene glycol)^distearoyl phosphati-
dylethanolamine (PEG-DSPE) in liposome
formulations has been shown to sterically stabilize
liposomes, resulting in signi¢cantly increased circula-
tion lifetimes, even in the presence of unsaturated or
anionic lipid components [16^18]. However, steric
stabilization also prevents aggregation and dehydra-
tion of membrane surfaces, and thus reduces lipo-
some fusion and contents release [19^21]. These re-
sults suggest signi¢cant improvements need to be
made to this variety of pH-sensitive liposomes for
in vivo drug delivery to become a reality.
Recent studies have demonstrated polymer coat-
ings may not only play a protective role, but may
participate in the drug release process by responding
to external stimuli such as temperature [22^24] and
pH [25,26]. Several recent studies have shown that
liposomes coated with hydrophobically modi¢ed co-
polymers of N-isopropylacrylamide (NIPA) acquire
thermoresponsive properties [22^24]. This tempera-
ture sensitivity triggers destabilization of the lipid
bilayers of liposomes, and consequently the release
of their contents in response to an increase in the
external temperature. The homopolymer of NIPA
is physically characterized by its lower critical solu-
tion temperature (LCST), which is approximately
32‡C in water [27]. The polymer is soluble below
its LCST, but undergoes a phase transition and col-
lapses when heated above it. A novel polymeric-
based pH sensitive liposome system has recently
been described by Meyer et al. [25]. By randomly
introducing a small proportion of titratable metha-
crylic acid (MAA) into NIPA copolymers, the LCST
rises above 37‡C and causes the polymer to be sensi-
tive to pH. Insertion of the copolymer in the phos-
pholipid bilayer resulted in a rapid and pH-sensitive
release of a water-soluble £uorescent marker from
the liposomes. Release was also shown to be depen-
dent on the presence of a hydrophobic anchor (octa-
decylacrylate, ODA), demonstrating the importance
of polymer binding in the destabilization process.
The present study is aimed at more carefully char-
acterizing the interaction of the copolymer with lipo-
somes and optimizing both the copolymer and lipo-
some composition for maximum release and
potential in vivo compatibility.
2. Materials and methods
2.1. Synthesis, molecular mass and phase transition
determination of (non) pyrene-labeled
copolymers
Polymers of di¡erent molecular masses were pre-
pared by random radical copolymerization in dis-
tilled 1,4-dioxane of NIPA, MAA and ODA (Al-
drich, Milwaukee, WI) with 2,2P-azobisisobutyro-
nitrile (AIBN) (0.06 mol%) (Eastman Kodak, Ro-
chester, NY) or 1,1P-azobis(cyclohexane carbonitrile)
(Aldrich) (ACCN) (0.12 mol%), used as the initiator.
Prior to polymerization, NIPA was puri¢ed by re-
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crystallization from heptane, solubilized by addition
of acetone, and then allowed to crystallize at 4‡C.
MAA was puri¢ed from its polymerization inhibitor
using an inhibitor remover disposable column for
hydroquinone and monomethylether hydroquinone
(Aldrich). AIBN and ACCN were puri¢ed as previ-
ously described [25].
The solution containing the monomers and the
initiator was degassed by bubbling N2 for 15 min
and then heated under stirring to 65‡C for 15 h.
Polymers were recovered by several reprecipitations
from diethylether [25], after solubilization in tetrahy-
drofuran (THF). Finally, in order to completely re-
move unreacted monomers and residual solvents,
polymers were dissolved in water, dialyzed (MWCO
6000^8000, Spectrum Laboratories, Laguna Hills,
CA) for 3 days and subsequently freeze-dried. The
percentage of MAA (pH-sensitive moiety) was ¢xed
at 5 mol% and determined by acid^base titration
[28]. The initial proportion of ODA (anchor) was
varied from 2^4 mol% (Table 1) and was measured
by 1H-NMR analysis, by comparing the proton sig-
nals of NIPA and ODA, respectively [28]. Labeled
copolymer was synthesized by introducing 1-pyrenea-
crylic acid (0.3 mol%) during polymerization. 1-Pyr-
eneacrylic acid was obtained from 1-pyrenecarboxy-
aldehyde and malonic acid and crystallized from
ethyl malonate [29,30]. Removal of free labeled
monomer was veri¢ed by thin-layer chromatography
(TLC) on aluminium sheets of silica gel 60 without
£uorescent indicator, eluted with diethylether/THF
80:20. The emission spectra of the labeled copolymer
and of 1-pyreneacrylic acid were determined to con-
¢rm the actual binding this latter to the polymer
(Fig. 1A,B). The weight- and number-average molec-
ular masses of polymers were determined by gel
chromatography in THF, using polystyrene stan-
dards. The number of anchors per polymer chain
(NODA) was calculated using the following equation
[25]:
NODA  MnPolymerf ODA=MwNIPAf NIPA
MwMAAf MAA MwODAf ODA 1
where MwK and fK are the molecular masses and the
molar fractions of comonomer K, respectively, and
MnPolymer the number-average molecular mass of
the copolymer.
The pH at which the polymer precipitates (25 Wg/
ml) was determined by 90‡ light scattering
(Vex =Vem = 480 nm) after incubation at 37‡C for
5 min in MES-bu¡ered saline (20 mM MES,
144 mM NaCl) of pH values ranging from 4.9 to
7.2 [25].
2.2. Liposome preparation and characterization
Unilamellar liposomes (20 mM total lipid) com-
posed of either EPC, EPC/Chol (3:2 molar ratio),
or EPC/Chol/PEG2000-DSPE (3:2:0.3 molar ratio)
(Avanti Polar Lipids, Alabaster, AL) were prepared
by the reverse-phase evaporation procedure [31], fol-
lowed by repeated extrusion through 0.1 Wm pore-
size membranes, at room temperature [32]. Particle
size distributions were determined by dynamic laser
light scattering (N4 Plus, Coulter Electronics, Hia-
leah, FL, USA). All liposome preparations had an
average size of 140^160 nm, with a coe⁄cient of
variation of 6 20% and an unimodal size distribu-
tion.
2.3. Free polymer separation and determination of
polymer binding to liposomes
Free polymer was removed by passage over a Se-
pharose 2B column (Pharmacia, Uppsala, Sweden,
i.d. 1 cm, length 23 cm), equilibrated with Hepes
bu¡er, pH 7.2 (20 mM Hepes, 144 mM NaCl) at
20‡C. To determine the polymer binding to liposo-
mal vesicles, pyrene-labeled copolymer was mixed
with liposomes at di¡erent mass ratios, and either
incubated overnight at 4‡C or incorporated during
the hydration step of liposome preparation. Phos-
pholipid concentrations were determined using the
Bartlett assay for total phosphate [33]. The amount
of polymer bound to liposomes was determined by
measuring the £uorescence (Vex = 346, Vem = 382 nm)
of fractions (1 ml) containing free pyrene-labeled
polymer following elution of the liposome-copolymer
complexes (100 Wl). This was compared to a calcu-
lated amount of labeled free copolymer eluted under
identical conditions.
2.4. In vitro release kinetics
Liposomes containing the highly water-soluble £u-
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orophore, HPTS, and the collisional quencher, DPX,
were prepared by including them in the lipid hydra-
tion bu¡er (20 mM Hepes, 35 mM HPTS, 50 mM
DPX, pH 7.2) prior to liposome formation. Un-
trapped dye was removed by gel ¢ltration using a
Sephadex G-100 resin (Pharmacia). Liposome^poly-
mer complexes were prepared as previously described
(see Section 3.1). The polymer^liposome complexes
(10 Wl, 0.2 Wg of total lipid) were added to the desired
bu¡er (2 ml; 20 mM MES, 144 mM NaCl, pH 4.9^
7.0) and the release of liposome contents was moni-
tored using a £uorescence dequenching assay [34].
The extent of contents release was calculated from
the £uorescence of HPTS (Vex = 413 nm, Vem = 512
nm) following a 3-min incubation in bu¡ers at vary-
ing pH and 37‡C, and made relative to the same
measurement following sample lysis in 0.1% (w/v)
Triton X-100 to give complete release of encapsu-
lated HPTS and DPX.
2.5. Lipid and aqueous content fusion assays
For lipid mixing experiments, liposomes composed
of EPC/Chol/N-NBD-PE/N-Rh-PE (3:2:0.05:0.05
molar ratio) were combined with unlabeled lipo-
somes composed of EPC/Chol (3:2 molar ratio) in
a 1:10 molar ratio. All liposomes were incubated
overnight at 4‡C, at a copolymer/lipid mass ratio
of 0.3. The mixed liposomes were injected into pH
7.2 and 4.5 bu¡ers, and £uorescence (Vex = 470 nm,
Vem = 520 nm) was measured continuously over time
(4.5 min). A 100% control liposome formulation
of EPC/Chol/N-NBD-PE/N-Rh-PE (3:2:0.005:0.005
molar ratio) was prepared and used as the standard
for 100% lipid mixing. Fluorescence resonance en-
ergy transfer experiments with N-NBD-PE and N-
Rh-PE demonstrate lipid mixing, which is necessary
for membrane fusion, by measuring the increase in
NBD £uorescence upon dilution of the lipid probes
in unlabeled membranes and caused by the reduced
amount of £uorescence-energy transfer from NBD to
rhodamine [35].
Mixing of vesicle contents was measured by a
modi¢ed method of Ellens et al. [36], encapsulating
17.5 mM HPTS in one population of EPC liposomes
incubated with copolymer and 96 mM DPX in the
other. Mixing of aqueous contents leads to a de-
crease in HPTS £uorescence as it becomes quenched
by DPX. These assays have been performed at var-
ious pH ranging from 4.9 to 7.4. The £uorescence of
HPTS was continuously measured at the pH-inde-
pendent isosbestic point (Vex = 413 nm, Vem = 512
nm).
3. Results
3.1. Binding studies
The binding of poly(NIPA-co-MAA-co-ODA) to
EPC liposomes was studied with a pyrene-labeled
copolymer containing approximately 2 mol% ODA
(Table 1). The content in ODA was twice that used
in our previous study [25] since it was expected that
the binding stability, as well as the extent of pH-
mediated release, could be improved by increasing
the amount of hydrophobic anchor in the copolymer.
The labeled copolymer was synthesized by adding
1-pyreneacrylic acid during the copolymerization re-
action. Once grafted to the polymer, the probe shows
Table 1
Characterization of (NIPA/MAA/ODA) copolymers
Initiator (mol%) Initial ODA content
(mol%)
Final ODA content
(mol%)
Mw Mn Mw/Mn NODA
AIBN (0.06) 1a n.a. 9756 4161 2.34 0.4b
AIBN (0.06) 2 (labeled) 2.5 31 066 11 370 2.73 2.5
AIBN (0.06) 2 1.6 44 633 19 189 2.24 2.7
ACCN (0.12) 2 2.9 16 779 5141 3.36 1.3
AIBN (0.06) 4 6.2 45 255 20 183 2.33 10.4
n.a., not available.
aFrom [25], di¡erent puri¢cation procedures.
bCalculated from using the initial ODA content.
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the £uorescence emission spectrum of monomeric
pyrene when excited at 346 nm (Fig. 1B), with a
slight bathochromic shift. According to the emission
spectrum, the pyrene-labeled polymer can be treated
as a single £uorophore, without regard to the forma-
tion of excimers commonly seen with higher concen-
trations of free pyrene [30,37]. In addition, as illus-
trated in Fig. 2, the presence of this hydrophobic
label (0.3 mol%) only slightly modi¢es the phase
transition of the copolymer, which occurs between
pH 5.1 and 5.7. This is likely due to the low amount
of pyrene present in the label introduced into the
polymer, which limits its hydrophobic contribution
to the phase transition [37].
Bound and free copolymer can be e¡ectively sep-
arated on a Sepharose 2B column (Fig. 2). The lipo-
somes eluted in the void volume (5 ml) whereas the
free copolymer appeared mainly in the 15-ml frac-
tion. The coelution of labeled copolymer and lipo-
somes indicates that the copolymer remains anchored
to liposomes as it moves through the column. Be-
cause the interaction of pyrene with the liposome
bilayer modi¢es its £uorescence spectrum [37], the
percentage of bound copolymer was calculated by
comparing the amount of free copolymer both before
(Fig. 2A) and after (Fig. 2B) incubation with lipo-
somes. It can be seen from Fig. 3 (inset) that increas-
ing concentrations of copolymer progressively satu-
rate the EPC liposome surface. Maximum binding
occurs at an initial copolymer/lipid mass ratio of
0.12 (binding e⁄ciency 30%). The data were ¢tted
to a Langmuir isotherm (Fig. 3). The calculated af-
¢nity constant and maximum binding capacity were
15 l/g and 0.038 (g copolymer/g lipid), respectively.
At this ratio, the number of molecules of polymer
per EPC liposome was estimated to be 460, assuming
that 150-nm liposomes contain 182 000 lipid mole-
cules/vesicle [38]. Comparatively, Ringsdorf et al.
[39] found that each 100-nm dimyristoyl phosphati-
dylcholine (DMPC) liposome can accommodate 35
molecules of poly(NIPA-co-ODA) (Mv = 360 000,
NODA = 16). This number is similar to the value cal-
culated here if the di¡erence in molecular mass be-
tween the two polymers is taken into account. Ac-
cordingly, an initial mass ratio not less than 0.12 was
used for all release studies to ensure surface satura-
Fig. 2. pH-Dependent phase transition of both pyrene-labeled
(solid) and non-labeled (empty) copolymers (NIPA/MAA/ODA
93:5:2 mol%, Mw = 31 066 and 44 633, respectively). Copoly-
mers were incubated at 37‡C for 5 min in MES bu¡ers of vary-
ing pH (4.9^7.2). Polymer phase transition was measured as an
increase in light scattering at 480 nm.
Fig. 1. Emission wavelength spectrum of (A) 1-pyreneacrylic
acid (Vex = 365 nm) and of (B) pyrene-labeled copolymer
(NIPA/MAA/ODA 93:5:2 mol%, Mw = 31 066) (Vex = 346 nm).
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tion in all preparations. The release studies were per-
formed at 0.3 and 0.6 copolymer/lipid mass ratio.
Since no signi¢cant di¡erences were observed at
these two concentrations, only the experiments per-
formed at the 0.3 ratio are presented in Section 3.2.
The binding of the same copolymer (W2 mol%
ODA) to liposomes of di¡ering lipid composition
was investigated, after overnight incubation (16 h)
at 4‡C (Fig. 4). The addition of Chol (40 mol%) to
EPC liposomes had no in£uence on copolymer bind-
ing, with equivalent binding ratios, in both formula-
tions. In contrast, the presence of PEG-DSPE (6
mol%) on the liposome surface strongly inhibited
copolymer ¢xation, with less than 1% of the copoly-
mer being liposome-associated. To overcome this re-
duced ¢xation e⁄cacy, the copolymer was dissolved
in the hydration bu¡er and added to the lipid mix-
ture prior to liposome formation. This way, the co-
polymer is incorporated during the vesicle formation
and has access to both sides of the bilayer, rather
than just one in the case where copolymer is added
to preformed liposomes. The result is a signi¢cant
increase in binding (0.077 g copolymer/g lipid) of
copolymer (Fig. 4), even in presence of PEG-DSPE
(6 mol%), suggesting this procedure allows a more
e⁄cient incorporation of the polymer into the lipo-
somal formulation.
3.2. In vitro release kinetics
In a previous study conducted with EPC liposomes
and SSL [25], we showed that a low molecular mass
pH-sensitive copolymer of NIPA (Mw 9756) bearing
1 mol% ODA could trigger the release of approxi-
mately 25% and 15% of liposomal contents at pH 4.9
and 5.5, respectively, without removing free polymer.
It can be seen from Fig. 6 that when the molecular
mass (Mw 44 633) and the ODA content (1.6 mol%)
are increased, a substantial improvement in maximal
release from EPC liposomes is obtained; indeed, re-
lease of up to 42% at pH 4.9 and 16% at pH 5.5,
after free polymer removal. In the presence of free
Fig. 5. E¡ect of lipid composition on copolymer binding to
liposomes. The pyrene-labeled copolymer (NIPA/MAA/ODA
93:5:2 mol%, Mw = 31 066) was either incubated 16 h at 4‡C
with the liposomes (I) or incorporated during liposome prepara-
tion (P) at an initial copolymer/lipid mass ratio of 0.12.
Mean þ S.D. (n = 3).
Fig. 4. Adsorption of labeled copolymer (NIPA/MAA/ODA
93:5:2 mol%, Mw = 31 066) on EPC liposomes according to a
Langmuir isotherm. C, equilibrium concentration of copolymer
(g/l) ; Y, amount (g) of copolymer adsorbed per gram of lipids.
Inset: binding of copolymer to EPC liposomes, as a function of
copolymer/lipid mass ratio, after 16 h incubation at 4‡C, after
size-exclusion chromatography on a Sepharose 2B column,
equilibrated with Hepes bu¡er (pH 7.2) at 20‡C.
Fig. 3. Separation of bound and free copolymer by size-exclu-
sion chromatography on a Sepharose 2B column, equilibrated
with Hepes bu¡er (pH 7.2) at 20‡C. Pyrene-labeled copolymers
(NIPA/MAA/ODA 93:5:2 mol%, Mw = 31 066) were eluted ei-
ther before (A) or after (B) incubation with EPC liposomes for
16 h at 4‡C.
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copolymer the release was 72% and 23% at pH 4.9
and 5.5 (not shown). This suggests either a slight
desorption of the copolymer during separation, or
the implication of the unbound polymer in the desta-
bilization process when not removed. Although less
likely, this latter hypothesis cannot be excluded since
polyelectrolytes such as poly(2-ethyl-acrylic acid)
(PEAA) in solution have been shown to bind to lipo-
somes upon a decrease in pH and induce the forma-
tion of pores in the lipid bilayer [26,40]. Accordingly,
unless otherwise speci¢ed, all subsequent release
studies were performed after removal of free copoly-
mer on a Sepharose 2B column.
According to Fig. 6, the coil^globule transition
(pH 5.1^5.7) of the polymer can be correlated to
the pH-triggered release, suggesting that anchoring
of the copolymer to liposomes does not modify its
phase-transition pH.
Fig. 7 compares the release of HPTS at pH 4.9 and
7.2 from liposomes di¡ering in lipid composition
after removal of free polymer. Despite the similar
binding of the two formulations (Fig. 5), a signi¢cant
increase of contents release (82%) was observed after
inclusion of Chol (40 mol%) (Fig. 7) at pH 4.9. How-
ever, some aggregation was observed with EPC/Chol
liposomes coated with the polymer, which cannot be
explained at the present time. In contrast, the pres-
ence of PEG-DSPE in the liposome formulation re-
sulted in minimal release of the tracer (Fig. 7). This
can be correlated to the low binding of the copoly-
Fig. 7. E¡ect of pH and lipid composition on HPTS release
from copolymer-bound liposomes, after free polymer removal
on a Sepharose 2B column, except for the formulation contain-
ing PEG-DSPE. The copolymer (NIPA/MAA/ODA 93:5:2
mol%, Mw = 44 633) was incubated overnight at 4‡C with lipo-
somes at an initial copolymer/lipid mass ratio of 0.3. Copoly-
mer-bound liposomes were incubated for 3 min at 37‡C at ei-
ther pH 7.2 (solid) or 4.9 (empty). HPTS release was measured
as an increase in HPTS £uorescence (Vex = 413 nm, Vem = 512
nm) following release from the liposomes. 100% contents release
was obtained by adding Triton X-100 and the data are ex-
pressed as percentage of total HPTS released. Mean þ S.D.
(n = 3).
Fig. 6. A comparison of the phase transition of the copolymer
(NIPA/MAA/ODA 93:5:2 mol%, Mw = 44 633) (E) and the re-
lease of HPTS from copolymer-bound EPC liposomes (8), as a
function of pH, after 16 h incubation at 4‡C at a copolymer/
lipid mass ratio of 0.3. All measurements were taken after free
polymer removal on a Sepharose 2B column. HPTS release was
measured as an increase in HPTS £uorescence (Vex = 413 nm,
Vem = 512 nm) following release from the liposomes. 100% con-
tents release was obtained by adding Triton X-100 and the data
are expressed as percentage of total HPTS released. Polymer
phase transition was measured as an increase in light scattering
at 480 nm.
Fig. 8. E¡ect of polymer composition and molecular weight on
HPTS release from EPC/Chol/PEG-DSPE liposomes. Lipo-
some^copolymer system was prepared by incubation 16 h at
4‡C with copolymer I (2% ODA, Mw = 16 778), copolymer II
(4% ODA, Mw = 45 255), or after incorporation of copolymer
III (2% ODA, Mw = 44 633) during the liposome preparation, at
an initial copolymer/lipid mass ratio of 0.3. All measurements
were taken after free polymer removal on a Sepharose 2B col-
umn. Copolymer bound liposomes were incubated for 3 min at
37‡C at either pH 7.2 (solid) or 4.9 (empty). HPTS release was
measured as an increase in HPTS £uorescence (Vex = 413 nm,
Vem = 512 nm) following release from the liposomes. 100% con-
tents release was obtained by adding Triton X-100 and the data
are expressed as percentage of total HPTS released.
Mean þ S.D. (n = 3).
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mer to SSL (Fig. 5). However, the release was even
lower than that obtained by Meyer et al. [25] after
incubation of the liposomes with a copolymer bear-
ing only 1 mol% ODA. We conjectured that the dif-
ference seen in release resulted from the di¡erence
between the molecular mass of the two copolymers.
In order to prove this hypothesis, a pH-sensitive co-
polymer containing approximately 2 mol% ODA and
with a Mw of 16 779 was synthesized (Table 1). This
resulted in a substantial increase in pH-triggered re-
lease (40%) (Fig. 8), which indirectly con¢rmed the
importance of the polymer weight in binding to SSL.
Moreover, we tested whether the steric repulsion pro-
vided by the PEG coating could be overcome by
further increasing the ODA content to 6.2 mol%,
while keeping a relatively high Mw (Table 1). As
shown in Fig. 8, some contents leakage (20%) could
be achieved with this copolymer. Another way of
circumventing the steric repulsion of PEG was to
incorporate the copolymer containing 1.6 mol%
ODA (Mw 44 633) during the hydration step of the
liposome preparation procedure. In this case, a 40%
release was observed (Fig. 8). With this method, no
di¡erence was observed in the release capacity of
SSL, before and after free polymer removal, which
can be attributed to the better ¢xation of the copoly-
mer with this incorporation method (data not
shown).
3.3. Fusion assays
To test whether pH-induced liposome destabiliza-
tion was due in part to membrane fusion, a lipid
mixing assay was utilized as described by Struck et
al. [35]. Mixing of membrane lipids between labeled
and unlabeled liposomes results in dilution of the
£uorescent probes and a decrease in £uorescence en-
ergy transfer between N-NBD-PE and N-Rh-PE. If
copolymer-bound liposomes are similar to other
membranes that undergo fusion, we would expect
to see an increase in the mixing of the lipid compo-
nents. This was compared to another liposome for-
mulation (suc-DOPE/DOPE, 1:9) previously shown
to fuse under conditions of low pH in the presence of
Ca2 (1 mM, Fig. 9). Suc-DOPE/DOPE liposomes
were shown to fuse and release water soluble con-
tents markers (HPTS and calcein) in response to de-
creases in pH and increases in Ca2 concentrations
(Drummond and Daleke, unpublished observations).
A modi¢ed version of this experiment shows rapid
lipid mixing as the pH is lowered from pH 7.4 to 4.5,
indicating a pH-dependent fusion of these liposomes.
Alternatively, the liposomes used for incorporation
of the copolymer contain high concentrations of
EPC and Chol, a combination usually refractory to-
wards fusion. However, as demonstrated above, sig-
ni¢cant drug leakage did occur at low pH in the
presence of bound copolymer. Lipid mixing experi-
ments with these liposomes, showed no lipid mixing
at pH 4.5 (Fig. 9). Lack of mixing of aqueous con-
tent con¢rmed the absence of fusion (data not
shown). These results suggest a transient destabiliza-
tion being responsible for contents leakage, rather
than membrane fusion, as shown for other pH-sensi-
tive liposome formulations.
4. Discussion
This study has shown an e¡ective binding of the
copolymer on liposomes, which can be ¢tted to a
Langmuir isotherm. The release under weakly acidic
conditions can be correlated to the amount of bound
Fig. 9. Mixing of membrane lipid components in copolymer
bound or suc-DOPE/DOPE (1:9) liposomes. EPC/Chol (3:2)
liposomes were incubated overnight at 4‡C with copolymer
(NIPA/MAA/ODA 93:5:2 mol%, Mw = 44 633). Labeled lipo-
somes (1% N-NBD-PE, 1% N-Rh-PE) were incubated at pH
4.5 (trace A) with unlabeled liposomes in a 1:9 ratio. An identi-
cal experiment was carried out with suc-DOPE/DOPE (1:9)
liposomes at pH 7.2 (trace B) or pH 4.5 (trace C) in the pres-
ence of 1 mM CaCl2. The mixed liposomes were injected into
pH 7.2 and 4.5 bu¡ers and £uorescence (Vex = 470 nm,
Vem = 520 nm) was measured continuously over time (4.5 min).
A 100% control liposome formulation of EPC/Chol/N-NBD-
PE/N-Rh-PE (3:2:0.005:0.005 molar ratio) was prepared and
used as the standard for 100% lipid mixing.
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copolymer and to the number of anchors per poly-
mer. Thus, when this number increases, the binding
e⁄cacy improves, as well as its ability to destabilize
the lipid bilayer upon acidi¢cation. Previous studies
have demonstrated that hydrophobically modi¢ed
NIPA copolymers could e⁄ciently bind liposomes
whether the latter were in the liquid-crystalline or
gel phase [22,24].
In the case of SSL, the molecular mass of the co-
polymer is relevant, since the presence of PEG-DSPE
chains could sterically inhibit the insertion of the
anchor in the liposomal membrane. Indeed, it is
well known that the steric interference of surface-as-
sociated PEG can signi¢cantly a¡ect the ability of
macromolecules such as plasma opsonins to bind to
the membrane surface [41^43]. The incorporation of
the copolymer during liposome preparation could
trigger a signi¢cant binding of this latter to the lipo-
somal bilayer. However, this method may not be
compatible with other liposomal technologies such
as drug-loading using pH [44], ammonium sulfate
gradients [45], or the hydration of high phase tran-
sition lipid compositions, because in both cases the
copolymer could precipitate. When combined with
these preparation procedures it would certainly be
preferable to bind the copolymer following lipid hy-
dration and drug loading to prevent premature de-
stabilization.
In our study, the coil^globule transition pH of the
polymer appears between pH 5.1 and 5.7 and is not
modi¢ed after its anchoring to liposomes. This has
been previously evidenced by Ringsdorf et al. [46] for
the LCST of hydrophobically modi¢ed poly(NIPA)
anchored to DMPC or distearoyl phosphatidylcho-
line (DSPC) liposomes using di¡erential scanning
calorimetry. However, a recent study by Winnik et
al. [47] showed that in presence of dimethyldioctade-
cylammonium bromide (DDAB) the LCST of modi-
¢ed poly(NIPA) could be decreased, depending on
lipid concentration. This phenomenon was attributed
to a gradual neutralization of the carboxylic acid
groups of the polymer by the cationic groups on
the liposome surface. This charge neutralization
mechanism competes with the pH-sensitive protona-
tion of the polymer and thus controls the cloud
point.
Once anchored to liposomes, the copolymer trig-
gers signi¢cant contents release below pH 5.5, which
corresponds to endosomal pH [48]. Comparatively,
pH-sensitive liposomes of DOPE/CHEMS show a
leakage of an aqueous marker below pH 5.5 [9,36],
whereas DOPE/OA liposomes are more sensitive and
release their contents below pH 6.5 [8].
The signi¢cant increase of contents release after
incorporating 40 mol% of Chol, compared to plain
EPC formulations, cannot be explained at the
present time. In fact, Liu and Huang [49] showed
that the addition of increasing concentrations of
Chol to pH-sensitive liposomes containing DOPE
and OA triggered a signi¢cant decrease in calcein
release in vitro. In their study, the percentage of
leakage content decreased linearly from 85% to
40% at pH 5, when the concentration of Chol in-
creased from 10 mol% to 40 mol%. Similarly, the
presence of Chol reduces the e⁄ciency of the peptide
GALA [50] and PEAA [51] to induce leakage at
acidic pH. While the addition of Chol has been re-
ported to decrease the membrane permeability of
phospholipid bilayers by e¡ecting tighter-packing lip-
ids, it can also promote membrane fusion by induc-
ing the formation of non-bilayer lipid phases [52].
In contrast, the addition of PEG-DSPE (6 mol%)
prevents the copolymer binding and thus triggered a
minimal pH-sensitive release. Several approaches
have been examined to improve contents release of
PEG containing formulations. First, it has been
shown that a decrease in the copolymer average mo-
lecular mass favors its insertion trough the PEG ster-
ic barrier. It has been described in depth that PEG
prevents the adsorption of macromolecules to the
liposome surface. To reach the liposome surface
macromolecules have to penetrate the conformation-
al ‘cloud’ formed by the PEG [41]. For this reason, it
can be anticipated that lower molecular mass poly-
mers may more readily reach the liposome surface.
A relative increase in the relative percentage of
ODA also improved the release e⁄ciency of the pe-
gylated system. This can be attributed to the ability
of the additional anchors to improve binding and to
favor the collapsed copolymer within the liposome
membrane.
The addition of copolymer during the liposome
preparation also markedly improves the release e⁄-
ciency compared to simple incubation with pre-
formed liposomes. In this case, the polymer is lo-
cated in both monolayers and could further
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destabilize the liposomal membrane. This could be
explained by a possible proton permeation triggered
by the acidic destabilization of the copolymer located
on the liposomal surface [53]. A similar improvement
has been reported with a lipopeptide equally distrib-
uted into both membrane lea£ets of EPC/Chol lipo-
somes [54]. This preparation procedure would also
encapsulate a certain amount free copolymer. The
actual in£uence of the encapsulated polymer has
not been investigated and is likely not relevant. How-
ever, the 40% release obtained with this method
proves that at least part of the polymer is present
at the surface of the liposomal bilayer and triggers
the acidic destabilization.
This study showed that optimized formulations
containing PEG-DSPE (6 mol%) have copolymer
on their surface and thus maintain their pH-sensitiv-
ity. This is a considerable advantage in cancer ther-
apy, considering the signi¢cant increase in circulation
lifetime and accumulation in tumors provided by its
inclusion which has been documented in several stud-
ies [17,18,55]. In fact, it has been described that the
presence of the hydrophilic polymer on the liposomal
surface prevents aggregation and membrane fusion,
which is the main mechanism for destabilization of
DOPE pH-sensitive liposomes, and it is generally
recognized that these stabilized formulations lose
their e⁄cacy in the presence of PEG [20,21,56]. Re-
cently, it was demonstrated that PEAA (Mw 30 000)
in solution (1 mg/ml) was able to destabilize lipo-
somes bearing PEG-DSPE under acidic conditions
[51]. It was suggested that the cross-structural area
of PEAA was small enough to allow the di¡usion
through the PEG layer and cause membrane disrup-
tion.
Lipid and aqueous content fusion assays have
shown that fusion is not involved in the leakage of
contents at acidic pH. However, since fusion may
depend on polymer concentration and structure,
and liposome composition, further studies are re-
quired to determine whether fusion can occur under
di¡erent conditions. For instance, Chen et al. [57]
showed that PEAA conjugated to EPC/Chol lipo-
somes promoted vesicle fusion at pH 5. It was hy-
pothesized that at this pH, the insertion of hydro-
phobic segments of PEAA into the membranes of
neighboring liposomes lead to close vesicle^vesicle
contact, facilitated local dehydration at the contact
site and caused defects in the packing of the mem-
brane lipids and eventually fusion. Hayashi et al. [23]
showed that hydrophobically modi¢ed poly(NIPA)
could trigger the fusion of dipalmitoyl phosphatidyl-
choline and DSPC liposomes at a temperature cor-
responding to the gel^liquid crystalline transition of
the lipid membranes. Since our experiments were
performed at a temperature exceeding the phase
transition of EPC, this phenomenon could not be
evidenced.
The mechanism involved in the acidic destabiliza-
tion of the vesicles by pH-sensitive copolymers of
NIPA remains to be elucidated. Transient reversible
destabilization of the liposomal membrane structural
integrity is a potential mechanism. This hypothesis is
suggested because during the polymer coil to globule
transition, the polymer remains anchored in the bi-
layer and the liposomes is not destroyed [37,46].
Transient membrane perturbation with or without
membrane fusion may explain why 100% release
was never achieved, although partial leakage could
also be due to the fact that some populations of
liposomes do not carry su⁄cient amounts of the
polymer on their membranes to induce a complete
release of their contents [22]. Moreover, it has been
proposed that above the LCST, poly(NIPA) bearing
C18 alkyl chains become more hydrophobic and con-
tract, creating ‘point defects’ or spaces in the extra-
liposomal lea£et and stimulate lipid £ip-£op [58]. By
analogy, the same phenomenon may occur with pH-
sensitive copolymers of NIPA at acidic pH. Also, it
has been suggested that above the LCST, hydro-
phobically modi¢ed poly(NIPA) gives rise to lipo-
some budding [59]. However, the formation of buds
has been observed for giant liposomes and is unlikely
for 150 nm liposomes.
Several points need to be veri¢ed, such as what
e¡ect the presence of the copolymer will have on
liposomes plasma stability and circulation time.
These experiments are presently being completed in
our laboratory. Also, in vitro and in vivo studies are
currently under way to determine the potential of
this novel copolymer^liposome system for the intra-
cellular delivery of drugs and to assess the toxicity of
NIPA copolymers. We have recently shown that co-
polymers of NIPA were not toxic in vitro towards
EMT-6 mouse mammary tumor cells at a concentra-
tion of 0.22 mg/ml [28] and do not trigger either local
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or systemic in£ammatory reactions at a concentra-
tion of 5 mg/ml, following subcutaneous injection
to rats [60].
Because of their great versatility in either being
compatible with a variety of lipid compositions or
being responsive to both pH and temperature, the
addition of pH-sensitive copolymers of NIPA repre-
sent a potential strategy for improving liposomal
drug delivery.
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